Fluroine-18 fluorodeoxyglucose-positron emission tomography/computer tomography in staging of renal cell carcinoma arising from a native kidney with liver and bone metastasis in a renal transplant patient

Renal cell carcinoma (RCC) of the native kidney accounts for <5% of all malignancies found in transplant recipients. There have been only a few reported cases comprising of few renal transplant patients with RCC of native kidneys due to the relative rarity of the condition. Fluorine-18 Fluorodeox...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of nuclear medicine Vol. 17; no. 4; pp. 296 - 298
Main Authors Kamaleshwaran, Koramadai, Rangarajan, Bharat, Jose, Raghi, Shinto, Ajit
Format Journal Article
LanguageEnglish
Published A-12, 2nd Floor, Sector 2, Noida-201301 UP, India Thieme Medical and Scientific Publishers Pvt. Ltd 01.10.2018
Wolters Kluwer India Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Medknow Publications & Media Pvt Ltd
Subjects
Case Report
Computed tomography
Cysts
Fluorine
Fluorine isotopes
Health risk assessment
Kidney cancer
Kidneys
Liver
Medical imaging
Metastasis
Patients
Positron emission
Radioisotopes
Tomography
Transplants & implants
Tumors
Ultrasonic imaging
renal cell carcinoma
Fluoride-18 Fluorodeoxyglucose-positron emission tomography/computed tomography
native kidney
renal transplant
Online AccessGet full text

Cover

More Information
Summary:Renal cell carcinoma (RCC) of the native kidney accounts for <5% of all malignancies found in transplant recipients. There have been only a few reported cases comprising of few renal transplant patients with RCC of native kidneys due to the relative rarity of the condition. Fluorine-18 Fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) is used in the staging of RCC. Prognosis of metastatic RCC is poor. We report the first case of 55-year-old postrenal transplant recipient diagnosed with RCC of the native kidney with liver and bone metastases imaged using F-18 FDG PET/CT.
ISSN:1450-1147
1607-3312
DOI:10.4103/wjnm.WJNM_65_17